Alba Redondo

MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry

Teresa Lopes Ramos, Luis Ignacio Sánchez‐Abarca, Sandra Muntión et al. · Cell Communication and Signaling · 2016 · 311 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease

Fermín Sánchez‐Guijo, Teresa Caballero‐Velázquez, Olga López‐Villar et al. · Biology of Blood and Marrow Transplantation · 2014 · 119 citations · Full text

Medicine, Hematology, Surgery +15

Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up

Juan F. Blanco, Eva M. Villarón, David Pescador et al. · Stem Cell Research & Therapy · 2019 · 63 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Lenalidomide in combination with R‐<scp>ESHAP</scp> in patients with relapsed or refractory diffuse large B‐cell lymphoma: a phase 1b study from <scp>GELTAMO</scp> group

Alejandro Martı́n, Alba Redondo, Iván Dlouhy et al. · British Journal of Haematology · 2016 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis

Teresa L. Ramos, Luis Ignacio Sánchez‐Abarca, Beatriz Rosón et al. · PLoS ONE · 2017 · 26 citations · Full text

Medicine, Cell Biology, Hematology +16